The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.

The surgery typically lasts between 1.5 to 3 hours, depending on the complexity of the procedure.